Heghine Khachatryan: Breaking Barriers in Bleeding Disorder Care for Women and Girls
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared European Association for Haemophilia and Allied Disorders (EAHAD)’s post on LinkedIn, adding:
”An exceptionally important and timely topic.
Women and girls with bleeding disorders have historically been underdiagnosed, undertreated, and underrepresented in both clinical research and healthcare policy.
Advancing equitable access to diagnosis, multidisciplinary care, reproductive health services, and evidence-based management throughout the lifespan should remain a global priority.
Education and awareness are fundamental drivers of this progress.
Thank you, EAHAD, for keeping this vital conversation at the forefront.”
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
”A focused look at the unmet needs of women and girls with bleeding disorders, from nursing roles and joint health to pregnancy challenges and gender diversity in care.
Missed the live session? Relive the insights anytime on EAHAD Academy”
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients